Eli Lilly defeated as Cialis patent found obvious on appeal
01-11-2017
Eli Lilly settles Cialis patent litigation with generic makers
18-07-2017
clu / iStockphoto.com
Eli Lilly is attempting to stop a Chinese company from manufacturing a generic version of blockbuster drug Cialis (tadalafil).
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Eli Lilly, generics, ANDA, Cialis, patent infringement, Sunshine Lake Pharma, HEC Pharm, FDA
